Carmichael Hill & Associates’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.81K | Buy |
57
+5
| +10% | +$334 | ﹤0.01% | 570 |
|
|
2024
Q2 | $6.18K | Buy |
52
+8
| +18% | +$950 | ﹤0.01% | 526 |
|
|
2024
Q1 | $4.69K | Hold |
44
| – | – | ﹤0.01% | 551 |
|
|
2023
Q4 | $4.38K | Sell |
44
-37
| -46% | -$3.68K | ﹤0.01% | 553 |
|
|
2023
Q3 | $8.37K | Hold |
81
| – | – | ﹤0.01% | 485 |
|
|
2023
Q2 | $9.84K | Hold |
81
| – | – | ﹤0.01% | 474 |
|
|
2023
Q1 | $12.4K | Hold |
81
| – | – | 0.01% | 442 |
|
|
2022
Q4 | $14.5K | Hold |
81
| – | – | 0.01% | 407 |
|
|
2022
Q3 | $10K | Hold |
81
| – | – | 0.01% | 468 |
|
|
2022
Q2 | $12K | Hold |
81
| – | – | 0.01% | 429 |
|
|
2022
Q1 | $14K | Sell |
81
-25
| -24% | -$4.32K | 0.01% | 439 |
|
|
2021
Q4 | $27K | Sell |
106
-13
| -11% | -$3.31K | 0.01% | 372 |
|
|
2021
Q3 | $46K | Buy |
119
+15
| +14% | +$5.8K | 0.02% | 288 |
|
|
2021
Q2 | $24K | Buy |
104
+47
| +82% | +$10.8K | 0.01% | 389 |
|
|
2021
Q1 | $7K | Hold |
57
| – | – | ﹤0.01% | 515 |
|
|
2020
Q4 | $6K | Sell |
57
-43
| -43% | -$4.53K | ﹤0.01% | 517 |
|
|
2020
Q3 | $7K | Sell |
100
-100
| -50% | -$7K | ﹤0.01% | 480 |
|
|
2020
Q2 | $13K | Buy |
+200
| New | +$13K | 0.01% | 389 |
|